← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 2001-04-19

Drug application

FDA Application #

ANDA075390

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN

Generic name

NAPROXEN

Active ingredients

NAPROXEN

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA USA

Manufacturer

Aurobindo Pharma Limited

First approval

2001-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown